Clinical Trial Update: Clinical Relationship Between Vitamin D-mediated Th17 and Treg Cells and Parkinson's Disease [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 trial completed evaluating how Vitamin D influences Th17 and Treg immune cells in Parkinson's disease, to explore a potential immune mechanism …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Vitamin D (Cholecalciferol) (Cholecalciferol)

Snippet

Sponsor: Suzhou Municipal Hospital of Anhui Province | Conditions: Neurology, Immunology | EARLY_Phase 1 | Status: COMPLETED